2021
DOI: 10.3389/fnagi.2021.710818
|View full text |Cite
|
Sign up to set email alerts
|

A Systematic Review of Transcranial Direct Current Stimulation in Primary Progressive Aphasia: Methodological Considerations

Abstract: A variety of tDCS approaches has been used to investigate the potential of tDCS to improve language outcomes, or slow down the decay of language competences caused by Primary Progressive Aphasia (PPA). The employed stimulation protocols and study designs in PPA are generally speaking similar to those deployed in post-stroke aphasic populations. These two etiologies of aphasia however differ substantially in their pathophysiology, and for both conditions the optimal stimulation paradigm still needs to be establ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 155 publications
(352 reference statements)
0
11
0
Order By: Relevance
“…A standard 1.5 mA stimulation was first planned, but during the pilot trial, the patient asked to decrease the intensity. Thus, 1 mA intensity was chosen in order to compromise between the literature and the patient's feelings [17]. The current was ramped up for 30 s at the beginning and ramped down for 15 s at the end of the stimulation.…”
Section: Tdcs Treatmentmentioning
confidence: 99%
See 1 more Smart Citation
“…A standard 1.5 mA stimulation was first planned, but during the pilot trial, the patient asked to decrease the intensity. Thus, 1 mA intensity was chosen in order to compromise between the literature and the patient's feelings [17]. The current was ramped up for 30 s at the beginning and ramped down for 15 s at the end of the stimulation.…”
Section: Tdcs Treatmentmentioning
confidence: 99%
“…However, most of the studies are of rather short therapy [13]. In their systematic review, Coemans et al (2021) [17] reported that 13 of the 17 studies focused stimulation sites on the main locus of atrophy in nfvPPA patients either with an anode placed in the left inferior frontal, corresponding to the F7 electrode in the EEG 10-20 electrode position system or in the left temporoparietal areas, and the cathode placed on the right fronto-orbital area, forehead, or right shoulder. Interestingly, a longitudinal study showed improved sentence processing and neurocognitive process changes after 18 months of speech therapy in a patient with nfvPPA [18].…”
Section: Introductionmentioning
confidence: 99%
“…Recent studies from different groups, including our own, have identified several baseline factors that predict efficacy of tDCS for a given patient or patient group [see [6][7][8] for reviews]. Five predictive factors have been identified: (1) baseline language and cognitive performance [9,10], (2) baseline cortical volume and thickness [11][12][13], (3) baseline white matter integrity [14], (4) clinical variant PPA [15], and (5) baseline sleep efficiency [16].…”
Section: Introductionmentioning
confidence: 99%
“…There is feasibility and efficacy of tDCS stimulation to trained items, as well as transfer of benefits to untrained items/words [46]. Investigation of factors that predict treatment response in PPA is at a nascent stage (see [7,8] for recent reviews) and is challenging, because PPA is a heterogenous clinical syndrome that includes at least three different clinical variants with varying patterns of decline [2]. Early prediction of treatment outcomes (before any treatment starts) is important in a neurodegenerative disorder because losing time means losing brain tissue.…”
Section: Introductionmentioning
confidence: 99%
“…Transcranial direct current stimulation (tDCS) has emerged as a strong candidate approach in the effort to maximize the effects of behavioral rehabilitation in PPA (for recent reviews see Nissim et al, 2020 ; Coemans et al, 2021 ). In relation to other neuromodulatory approaches, tDCS advantages include good tolerance and portability for clinical use ( Nissim et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%